[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"blood-pressure-monitoring-ambulatory\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:blood-pressure-monitoring-ambulatory":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,69],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":4},"100643350","multi-centre-based-evaluation-of-the-performance-and-safety-of-the-corsano-cardiowatch-287-2-blood-pressure-monitoring-device-at-wrist-against-bp-cuff-measurements-cor-bp-100643350",false,"NCT07633886","Multi-Centre Based Evaluation of the Performance and Safety of the Corsano CardioWatch 287-2 Blood Pressure Monitoring Device at Wrist Against BP-Cuff Measurements (COR-BP)","COR-BP","Inclusion Criteria:\n\n* Participants must be able to provide informed consent to participate.\n* Participants must be willing and able to comply with all of the study procedures and return for at least 3 visits.\n* Participant or witness must be able to read or write in Dutch or English.\n* Applicable for group A: Participant must be 22 to 50 years of age.\n* Applicable for group B: Participant must be over 50 years of age.\n\nExclusion Criteria:\n\n* Participants with compromised circulation, injury, or physical malformation of the equipment test sites or other sensor sites which would limit the ability to test sites needed for the study. (Note: Certain malformations may still allow participants to participate if the condition is noted and would not affect the sites utilized).\n* Female participants who are known to be pregnant or who are trying to get pregnant confirmed by a day 1 positive urine pregnancy test unless the study participant is known to be not of child-bearing potential.\n* Participants with known clotting disorders or currently taking a prescription blood thinner.\n* Other known health conditions that will prevent safe participation in the study upon disclosure in Health Assessment Short Form or verbally.\n* Participants suffering from sustained cardiac arrhythmias that can lead to weak or unstable pressure pulses including tachycardia (heart rate at rest \\> 120bpm) and atrial fibrillation.\n* Participants suffering from pathologies that systematically reduce peripheral perfusion including Raynaud's disease, diabetes, renal dysfunctions (eGFR \\\u003C 60mL \u002F min \u002F 1.73 m2), hyper- \u002F hypothyroidism, pheochromocytoma or arteriovenous fistula.\n* Participants with known aortic arch pathology or prior surgical intervention involving the aortic arch or descending aorta (e.g., coarctation repair, vascular grafting, or stenting), which may interfere either with accurate peripheral blood pressure measurement.\n* A wrist circumference below 14 cm or above 23 cm.\n* An upper arm circumference \\\u003C 22cm or \\> 42cm.\n* Any subject that, in the opinion of the investigator, does not exhibit any phenotype relevant to the objectives of this study (i.e. to ensure all sub-groups have adequate representation).\n* Any condition or circumstance that, in the opinion of the investigator, may preclude study completion, interfere with accurate data collection, bias the results, by instance a subject presenting a lateral Blood Pressure difference at screening of more than 15 mmHg for the systolic and\u002For more than 10 mmHg for the diastolic.\n\nAdditional criteria that will be pursued for ensuring demographic diversity consist of the following patient characteristics according to FDA recommendations concerning the diversity of clinical trial populations \\[6\\]:\n\n* Gender, at least:\n\n  * 40% female;\n  * 40% male.\n* Skin Colour, at least:\n\n  * 25% Monk skin tone (MST) 1-3;\n  * 25% MST 4-6;\n  * 25% MST 7-10 including subjects with MST 9 and MST 10.\n* BMI, at least:\n\n  * 5% Underweight (\\\u003C18.5)\n  * 20% Normal weight (18.5-24.9)\n  * 20% Overweight (25-29.9)\n  * 20% Obese (≥30.0)","ALL","22 Years",{"count":19,"type":20},170,"ESTIMATED","OBSERVATIONAL","The Corsano CardioWatch 287-2 is a medical wearable device that can monitor blood pressure. The device has been validated using clinical trials in hospitals. The aim of this study is to further evaluate blood pressure measurements by the CardioWatch 287-2 in the intended remote setting across various demographic groups.\n\nPrimary objective: To assess the difference in blood pressure measurements obtained by the Corsano CardioWatch 287-2 and auscultatory blood pressure monitoring over a period of 31 days.\n\nSecondary objective: To assess the usability of the Corsano CardioWatch 287-2 from a patient perspective.\n\nParticipants receiving multiple standardized paired auscultatory and Corsano CardioWatch blood pressure measurements over a 31-day period. The study group will include patients of different ages (above the age of 22 years), genders, and demographics.",[24],"Blood Pressure Monitoring, Ambulatory",[26,27,28,29],"Blood pressure","Remote monitoring","Wearable","Corsano CardioWatch","NOT_YET_RECRUITING","2026-06-05",{"date":33,"type":34},"2026-06-08","ACTUAL",{"date":36,"type":20},"2026-06",{"date":38,"type":20},"2026-09",{"name":40,"class":41},"Corsano Health B.V.","INDUSTRY",{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":50,"maxAge":4,"enrollmentInfo":51,"targetDuration":53,"studyType":21,"phases":4,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":64,"leadSponsor":66,"locationsCount":4},"100608384","nocturnal-blood-pressure-dipping-and-ventricular-repolarization-in-hypertension-100608384","NCT07200856","Nocturnal Blood Pressure Dipping and Ventricular Repolarization in Hypertension","Impact of Nocturnal Blood Pressure Dipping on Ventricular Repolarization in Hypertensive Patients","NBP-DIP","Inclusion Criteria:\n\n* Adults ≥18 years old\n* Diagnosed with essential hypertension\n* Completed 24-hour ambulatory blood pressure monitoring (ABPM)\n* Availability of good-quality 12-lead ECG\n* Availability of good-quality transthoracic echocardiography\n\nExclusion Criteria:\n\n* Body mass index (BMI) \\> 34.9 kg\u002Fm²\n* Atrial fibrillation or atrial flutter\n* Use of QT-prolonging medications\n* End-stage renal disease or liver failure\n* Bundle branch block or presence of pacemaker\n* Prior coronary revascularization (PCI or CABG)\n* Significant electrolyte imbalance","18 Years",{"count":52,"type":20},140,"1 Day","The primary aim is to determine whether non-dipping status is associated with adverse repolarization markers and impaired myocardial mechanics compared to dipper hypertensive patients. Secondary analyses will compare these findings among resistant vs. non-resistant and controlled vs. uncontrolled hypertensive groups. This study may provide new insights into the prognostic significance of blood pressure dipping patterns in hypertensive patients.",[56,24,57,58,59],"Hypertension","Circadian Rhythm","Electrocardiography","Ventricular Function","2025-09-23",{"date":62,"type":34},"2025-10-01",{"date":62,"type":20},{"date":65,"type":20},"2027-01-01",{"name":67,"class":68},"Assiut University","OTHER",{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":77,"sex":78,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":4,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":91,"overallStatus":97,"whyStopped":4,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":107},"100581069","impact-of-resistance-training-intensity-on-blood-pressure-100581069","NCT06845514","Impact of Resistance Training Intensity on Blood Pressure","High Blood Pressure and Effect of Acute Resistance Training: Influence of Different Load Intensities on Postexercise Hypotension and Ambulatory Blood Pressure in Aging Females","HEART","Inclusion Criteria:\n\n* aged 50 to 70 years;\n* absence of menstruation for 12 consecutive months;\n* normal-high resting blood pressure (120 ≤ Systolic ≤ 139 mmHg and 80 ≤ Diastolic ≤ 89 mmHg) or stage 1 hypertension (140 ≤ Systolic ≤ 159 mmHg or 90 \\\u003C Diastolic ≤ 99 mmHg);\n* physically inactive (\\\u003C 150 minutes of structured aerobic physical activity per week);\n* and not engaging in regular resistance exercise (≥ 2 sessions per week) for more than 3 months during the year.\n\nExclusion Criteria:\n\n* orthopedic limitations or other contraindications to resistance exercise;\n* scheduled surgery during the study;\n* unstable hypertension (≥ 160\u002F100 mmHg);\n* diagnosis of type 2 diabetes;\n* cardiovascular event in the past 6 months or sequelae preventing exercise;\n* and initiation of hormonal replacement therapy (\\\u003C 4 months) known to affect blood pressure.",true,"FEMALE","50 Years","70 Years",{"count":82,"type":20},36,"INTERVENTIONAL",[85],"NA","The goal of the clinical trial is to understand the effect of two resistance training protocols employing different loading intensities (% of 1 repetition maximum; 1-RM), but with standardized effort intensity (2 repetitions in reserve; RIR) on post-exercise and ambulatory blood pressure in aging females.\n\nThe main questions it aims to answer are:\n\n* to examine the acute effects of low (50% 1-RM) and high (80% 1-RM) load intensity resistance exercise with a standardized high effort intensity on post-exercise hypotension and ambulatory blood pressure responses in aging females;\n* deepen the understanding of the mechanisms underlying acute reductions in blood pressure in response to resistance exercise performed at different load intensities. To this end, autonomic activity will be estimated alongside the measurement of central arterial compliance (i.e., carotid artery), and serum biomarkers of endothelial function;\n* document the affective valence and enjoyment associated with low (50% 1-RM) and high (80% 1-RM) load intensity resistance exercise when performed at a high perceived effort.\n\nResearchers will compare the effect of: 1) a low load (LL-RE) intensity protocol consisting of 3 sets of each exercise at 50% 1-RM, performed until reaching a hard perceived effort intensity (i.e., RIR-2); 2) high load (HL-RE) intensity protocol consisting of 3 sets of each exercise at 80% of 1-RM, performed until reaching a hard perceived effort intensity (i.e., RIR-2); 3) and a control condition (CON) consisting of a standardized non-fatiguing cognitive task.\n\nParticipants will participate in:\n\n* A preliminary assessment visit;\n* Two familiarization visits to validate the exercise prescriptions;\n* Three experimental visits (CON, LL-RE, HL-RE).",[88,24,89,90],"Blood Pressure Management","Blood Pressure, High","Blood Pressure",[92,93,94,95,96],"resistance training","ambulatory blood pressure","aging females","load intensity","perceived effort","RECRUITING","2025-09-02",{"date":100,"type":34},"2025-09-09",{"date":102,"type":34},"2025-07-08",{"date":104,"type":20},"2028-12",{"name":106,"class":68},"Université de Sherbrooke",1]